CN Stock MarketDetailed Quotes

301301 Yili Chuanning Biotechnology

Watchlist

13.30
+0.06+0.45%

Market Closed May 31 15:00 CST

29.62BMarket Cap26.49P/E (TTM)

Yili Chuanning Biotechnology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q9)Sep 30, 2021

Assets

Current assets

Money funds

-13.74%889.72M

-53.37%760.94M

278.95%1.1B

128.80%1.18B

--1.03B

219.97%1.63B

-47.19%290.83M

--517.74M

-0.03%510.05M

--550.67M

Transactional financial assets

----

--0

----

-4.80%1.15M

----

187.45%1.21M

--385.31K

Notes receivable and accounts receivable

-19.57%821.45M

-14.76%748.09M

-15.35%907M

-4.44%931.86M

--1.02B

12.39%877.6M

26.79%1.07B

--975.21M

-5.89%780.82M

--845.02M

-Notes receivable

----

--26.27M

-Accounts receivable

-19.57%821.45M

-14.76%748.09M

-15.35%907M

-4.44%931.86M

--1.02B

12.39%877.6M

30.86%1.07B

--975.21M

-5.89%780.82M

--818.75M

Other receivables (including interest and dividends)

-17.33%1.39M

-75.64%631.29K

-18.01%2.01M

27.42%1.89M

--1.68M

117.74%2.59M

-21.37%2.45M

--1.48M

-31.19%1.19M

--3.11M

-Other receivable

----

27.42%1.89M

----

117.74%2.59M

----

--1.48M

-31.19%1.19M

--3.11M

Advance payment

-0.66%131.04M

-47.17%44.9M

4.24%360.64M

-0.24%110.33M

--131.91M

38.16%84.99M

49.59%345.96M

--110.6M

-35.41%61.52M

--231.28M

Inventories

27.56%1.36B

21.16%1.68B

-20.73%876.82M

-24.32%925.62M

--1.07B

-4.81%1.38B

-7.19%1.11B

--1.22B

0.33%1.45B

--1.19B

Receivable financing

28.13%1.11B

21.48%655.4M

-18.53%640.75M

15.07%628.07M

--869.04M

35.81%539.5M

45.72%786.46M

--545.83M

1.77%397.25M

--539.7M

Other current assets

663.00%50.98M

1,020.40%70.04M

741.80%25.63M

336.25%12.62M

--6.68M

-41.05%6.25M

-25.16%3.04M

--2.89M

-73.24%10.6M

--4.07M

Total current assets

5.81%4.37B

-12.62%3.96B

8.56%3.91B

12.38%3.79B

--4.13B

40.78%4.53B

7.14%3.61B

--3.38B

-3.01%3.22B

--3.37B

Non Current assets

Other equity investment

--25M

--0

----

Long-term equity investment

-2.28%6.74M

-2.10%6.78M

70.90%6.82M

--6.87M

--6.9M

--6.93M

--3.99M

----

--0

----

Fixed assets

----

-7.75%5.23B

----

-6.05%5.47B

----

--5.67B

-1.99%5.82B

--5.94B

Constru in process

----

253.34%131.52M

----

-37.62%60.12M

----

--37.22M

-72.93%96.38M

--94.6M

Intangible assets

-9.43%251.45M

-8.86%257.99M

-8.67%264.53M

-8.48%271.08M

--277.64M

4.13%283.07M

4.39%289.63M

--296.18M

28.50%271.83M

--277.45M

Development expenditure

----

--940.18K

----

Goodwill

0.00%1.37M

--1.37M

0.00%1.37M

--1.37M

0.00%1.37M

--1.37M

Long deferred expense

-28.57%2.2M

-29.02%2.42M

-29.39%2.63M

-29.70%2.85M

--3.07M

-27.88%3.4M

-24.73%3.73M

--4.06M

379.99%4.72M

--4.96M

Deferred tax assets

69.29%21.3M

90.99%21.65M

116.31%19.99M

72.62%16.65M

--12.58M

62.92%11.34M

30.27%9.24M

--9.65M

73.16%6.96M

--7.09M

Usufruct assets

-11.65%190.07M

1,582.76%191.52M

1,528.99%193.38M

1,602.92%210.5M

--215.14M

179.33%11.38M

173.52%11.87M

--12.36M

-20.69%4.07M

--4.34M

Other non current assets

-26.45%24.99M

20.45%21.64M

280.13%169.34M

98.45%89.67M

--33.98M

-56.11%17.97M

16.49%44.55M

--45.19M

-24.83%40.94M

--38.24M

Total non current assets

3.67%6.21B

5.45%6.18B

2.82%6.13B

-1.88%5.97B

--5.99B

-6.13%5.86B

-6.41%5.96B

--6.08B

-5.51%6.25B

--6.37B

Total assets

4.55%10.57B

-2.42%10.14B

4.99%10.04B

3.21%9.76B

--10.11B

9.82%10.39B

-1.73%9.57B

--9.46B

-4.67%9.46B

--9.73B

Liabilities

Current liabilities

Short term loan

-3.38%850.75M

-13.09%850.68M

-21.66%658.47M

-19.17%679.53M

--880.52M

39.76%978.83M

31.22%840.48M

--840.66M

-11.43%700.35M

--640.53M

Transactional financial liabilities

-49.14%551.43K

--31.5K

-77.66%665.89K

316.82%4.24M

--1.08M

--0

--2.98M

--1.02M

----

Notes payable and accounts payable

68.23%985.26M

36.45%1.01B

20.13%756.93M

8.32%650.65M

--585.65M

-20.13%740.5M

-22.84%630.08M

--600.68M

-0.64%927.16M

--816.6M

-Notes payable

--293.46M

166.79%293.46M

-36.36%70M

--70M

----

-57.04%110M

-32.43%110M

----

0.26%256.03M

--162.8M

-Accounts payable

18.12%691.79M

13.71%716.96M

32.08%686.93M

-3.34%580.65M

--585.65M

-6.05%630.5M

-20.45%520.08M

--600.68M

-0.98%671.13M

--653.8M

Contract liabilities

356.11%55.36M

-23.84%28.94M

706.35%77.97M

887.83%134.06M

--12.14M

78.73%38M

40.05%9.67M

--13.57M

34.79%21.26M

--6.9M

Advance receipts

----

--0

----

Salaries payable

10.31%24.83M

13.04%29.94M

31.87%23.02M

11.43%23.92M

--22.51M

31.08%26.48M

-25.37%17.46M

--21.47M

-8.37%20.2M

--23.39M

Taxs payable

102.66%139.8M

-26.34%38.43M

71.79%94M

129.13%103.39M

--68.98M

5,869.63%52.18M

25.10%54.72M

--45.12M

-76.29%874.1K

--43.74M

Other payable (including interest and dividends)

27.01%33.62M

82.85%31.66M

908.80%28.35M

59.27%34.06M

--26.47M

61.30%17.32M

-61.35%2.81M

--21.39M

118.60%10.74M

--7.27M

-Interest payable

--0

----

-Dividend payable

--0

----

-Other payable

--33.62M

82.85%31.66M

----

59.27%34.06M

----

61.30%17.32M

----

--21.39M

118.60%10.74M

--7.27M

Non current liabilities due within one year

-55.10%382.99M

-36.15%542.16M

21.23%762.47M

21.26%762.79M

--853.06M

-3.42%849.13M

0.01%628.93M

--629.04M

39.72%879.19M

--628.83M

Other current liabilities

346.38%7.02M

-30.31%3.44M

702.46%10.04M

891.28%17.37M

--1.57M

58.13%4.94M

39.59%1.25M

--1.75M

61.57%3.12M

--896.06K

Total current liabilities

1.15%2.48B

-6.34%2.54B

10.21%2.41B

10.82%2.41B

--2.45B

5.64%2.71B

0.93%2.19B

--2.17B

6.72%2.56B

--2.17B

Current liabilities

Long term loan

-52.79%483M

-74.98%357.33M

-69.00%692.33M

--1.02B

-31.74%1.43B

-17.51%2.23B

--2.23B

-26.49%2.09B

--2.71B

Estimate liabilities

-43.84%1.41M

--77.9K

--5.33M

--3.41M

--2.51M

--0

----

Deferred tax liabilities

-97.09%20.7K

268.49%307.28K

--882.58K

--595.63K

--712.39K

--83.39K

----

--0

----

Long term deferred income

148.16%82.34M

144.56%83.74M

246.14%82.66M

123.37%55.11M

--33.18M

30.59%34.24M

39.59%23.88M

--24.67M

231.07%26.22M

--17.11M

Lease liabilities

-10.67%193.7M

1,743.84%188.12M

1,681.27%186.09M

1,779.90%199.86M

--216.83M

226.35%10.2M

208.53%10.45M

--10.63M

-24.69%3.13M

--3.39M

Other non current liabilities

----

--0

----

Total non current liabilities

-40.41%760.47M

-57.25%629.58M

-57.34%967.3M

-58.06%951.32M

--1.28B

-30.59%1.47B

-16.87%2.27B

--2.27B

-25.78%2.12B

--2.73B

Total liabilities

-13.08%3.24B

-24.27%3.17B

-24.16%3.38B

-24.35%3.36B

--3.73B

-10.77%4.18B

-8.99%4.46B

--4.44B

-10.94%4.68B

--4.9B

Shareholders equity

Paid-in capital

0.00%2.22B

11.14%2.22B

--2.22B

11.14%2.22B

0.00%2B

--2B

0.00%2B

--2B

Capital reserve funds

0.91%3.26B

0.69%3.25B

33.45%3.24B

33.09%3.23B

--3.23B

32.87%3.23B

0.00%2.43B

--2.43B

0.00%2.43B

--2.43B

Surplus reserve funds

132.85%172.32M

117.80%74M

--74M

117.80%74M

48.07%33.98M

--33.98M

48.07%33.98M

--22.95M

Retained profit

95.20%1.67B

93.71%1.31B

73.96%1.11B

58.56%862.36M

--853.66M

121.12%678.21M

68.92%639.01M

--543.87M

48.60%306.72M

--378.3M

Less:Treasury stock

--0

----

Other composite income

--0

----

Ordinary risk reserve funds

--0

----

Specific reserves

--0

----

Shareholders equity without minority interests

14.74%7.32B

12.18%6.96B

30.34%6.65B

27.67%6.39B

--6.38B

30.04%6.2B

5.62%5.1B

--5.01B

2.39%4.77B

--4.83B

Minority interests

114.65%12.88M

114.47%12.87M

81.12%10.87M

-0.00%6M

--6M

-0.01%6M

-0.02%6M

--6M

0.01%6M

--6M

Total shareholder equity

14.83%7.33B

12.28%6.97B

30.40%6.66B

27.63%6.4B

--6.39B

30.00%6.21B

5.62%5.11B

--5.01B

2.39%4.78B

--4.84B

Total liabilityies and equity

4.55%10.57B

-2.42%10.14B

4.99%10.04B

3.21%9.76B

--10.11B

9.82%10.39B

-1.73%9.57B

--9.46B

-4.67%9.46B

--9.73B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q9)Sep 30, 2021
Assets
Current assets
Money funds	-13.74%889.72M	-53.37%760.94M	278.95%1.1B	128.80%1.18B	--1.03B	219.97%1.63B	-47.19%290.83M	--517.74M	-0.03%510.05M	--550.67M
Transactional financial assets	----	----	----	--0	----	-4.80%1.15M	----	----	187.45%1.21M	--385.31K
Notes receivable and accounts receivable	-19.57%821.45M	-14.76%748.09M	-15.35%907M	-4.44%931.86M	--1.02B	12.39%877.6M	26.79%1.07B	--975.21M	-5.89%780.82M	--845.02M
-Notes receivable	----	----	----	----	----	----	----	----	----	--26.27M
-Accounts receivable	-19.57%821.45M	-14.76%748.09M	-15.35%907M	-4.44%931.86M	--1.02B	12.39%877.6M	30.86%1.07B	--975.21M	-5.89%780.82M	--818.75M
Other receivables (including interest and dividends)	-17.33%1.39M	-75.64%631.29K	-18.01%2.01M	27.42%1.89M	--1.68M	117.74%2.59M	-21.37%2.45M	--1.48M	-31.19%1.19M	--3.11M
-Other receivable	----	----	----	27.42%1.89M	----	117.74%2.59M	----	--1.48M	-31.19%1.19M	--3.11M
Advance payment	-0.66%131.04M	-47.17%44.9M	4.24%360.64M	-0.24%110.33M	--131.91M	38.16%84.99M	49.59%345.96M	--110.6M	-35.41%61.52M	--231.28M
Inventories	27.56%1.36B	21.16%1.68B	-20.73%876.82M	-24.32%925.62M	--1.07B	-4.81%1.38B	-7.19%1.11B	--1.22B	0.33%1.45B	--1.19B
Receivable financing	28.13%1.11B	21.48%655.4M	-18.53%640.75M	15.07%628.07M	--869.04M	35.81%539.5M	45.72%786.46M	--545.83M	1.77%397.25M	--539.7M
Other current assets	663.00%50.98M	1,020.40%70.04M	741.80%25.63M	336.25%12.62M	--6.68M	-41.05%6.25M	-25.16%3.04M	--2.89M	-73.24%10.6M	--4.07M
Total current assets	5.81%4.37B	-12.62%3.96B	8.56%3.91B	12.38%3.79B	--4.13B	40.78%4.53B	7.14%3.61B	--3.38B	-3.01%3.22B	--3.37B
Non Current assets
Other equity investment	--25M	--0	----	----	----	----	----	----	----	----
Long-term equity investment	-2.28%6.74M	-2.10%6.78M	70.90%6.82M	--6.87M	--6.9M	--6.93M	--3.99M	----	--0	----
Fixed assets	----	----	----	-7.75%5.23B	----	-6.05%5.47B	----	--5.67B	-1.99%5.82B	--5.94B
Constru in process	----	----	----	253.34%131.52M	----	-37.62%60.12M	----	--37.22M	-72.93%96.38M	--94.6M
Intangible assets	-9.43%251.45M	-8.86%257.99M	-8.67%264.53M	-8.48%271.08M	--277.64M	4.13%283.07M	4.39%289.63M	--296.18M	28.50%271.83M	--277.45M
Development expenditure	----	----	----	--940.18K	----	----	----	----	----	----
Goodwill	0.00%1.37M	0.00%1.37M	0.00%1.37M	0.00%1.37M	--1.37M	0.00%1.37M	0.00%1.37M	--1.37M	0.00%1.37M	--1.37M
Long deferred expense	-28.57%2.2M	-29.02%2.42M	-29.39%2.63M	-29.70%2.85M	--3.07M	-27.88%3.4M	-24.73%3.73M	--4.06M	379.99%4.72M	--4.96M
Deferred tax assets	69.29%21.3M	90.99%21.65M	116.31%19.99M	72.62%16.65M	--12.58M	62.92%11.34M	30.27%9.24M	--9.65M	73.16%6.96M	--7.09M
Usufruct assets	-11.65%190.07M	1,582.76%191.52M	1,528.99%193.38M	1,602.92%210.5M	--215.14M	179.33%11.38M	173.52%11.87M	--12.36M	-20.69%4.07M	--4.34M
Other non current assets	-26.45%24.99M	20.45%21.64M	280.13%169.34M	98.45%89.67M	--33.98M	-56.11%17.97M	16.49%44.55M	--45.19M	-24.83%40.94M	--38.24M
Total non current assets	3.67%6.21B	5.45%6.18B	2.82%6.13B	-1.88%5.97B	--5.99B	-6.13%5.86B	-6.41%5.96B	--6.08B	-5.51%6.25B	--6.37B
Total assets	4.55%10.57B	-2.42%10.14B	4.99%10.04B	3.21%9.76B	--10.11B	9.82%10.39B	-1.73%9.57B	--9.46B	-4.67%9.46B	--9.73B
Liabilities
Current liabilities
Short term loan	-3.38%850.75M	-13.09%850.68M	-21.66%658.47M	-19.17%679.53M	--880.52M	39.76%978.83M	31.22%840.48M	--840.66M	-11.43%700.35M	--640.53M
Transactional financial liabilities	-49.14%551.43K	--31.5K	-77.66%665.89K	316.82%4.24M	--1.08M	--0	--2.98M	--1.02M	----	----
Notes payable and accounts payable	68.23%985.26M	36.45%1.01B	20.13%756.93M	8.32%650.65M	--585.65M	-20.13%740.5M	-22.84%630.08M	--600.68M	-0.64%927.16M	--816.6M
-Notes payable	--293.46M	166.79%293.46M	-36.36%70M	--70M	----	-57.04%110M	-32.43%110M	----	0.26%256.03M	--162.8M
-Accounts payable	18.12%691.79M	13.71%716.96M	32.08%686.93M	-3.34%580.65M	--585.65M	-6.05%630.5M	-20.45%520.08M	--600.68M	-0.98%671.13M	--653.8M
Contract liabilities	356.11%55.36M	-23.84%28.94M	706.35%77.97M	887.83%134.06M	--12.14M	78.73%38M	40.05%9.67M	--13.57M	34.79%21.26M	--6.9M
Advance receipts	----	----	----	--0	----	----	----	----	----	----
Salaries payable	10.31%24.83M	13.04%29.94M	31.87%23.02M	11.43%23.92M	--22.51M	31.08%26.48M	-25.37%17.46M	--21.47M	-8.37%20.2M	--23.39M
Taxs payable	102.66%139.8M	-26.34%38.43M	71.79%94M	129.13%103.39M	--68.98M	5,869.63%52.18M	25.10%54.72M	--45.12M	-76.29%874.1K	--43.74M
Other payable (including interest and dividends)	27.01%33.62M	82.85%31.66M	908.80%28.35M	59.27%34.06M	--26.47M	61.30%17.32M	-61.35%2.81M	--21.39M	118.60%10.74M	--7.27M
-Interest payable	--0	--0	----	----	----	----	----	----	----	----
-Dividend payable	--0	--0	----	----	----	----	----	----	----	----
-Other payable	--33.62M	82.85%31.66M	----	59.27%34.06M	----	61.30%17.32M	----	--21.39M	118.60%10.74M	--7.27M
Non current liabilities due within one year	-55.10%382.99M	-36.15%542.16M	21.23%762.47M	21.26%762.79M	--853.06M	-3.42%849.13M	0.01%628.93M	--629.04M	39.72%879.19M	--628.83M
Other current liabilities	346.38%7.02M	-30.31%3.44M	702.46%10.04M	891.28%17.37M	--1.57M	58.13%4.94M	39.59%1.25M	--1.75M	61.57%3.12M	--896.06K
Total current liabilities	1.15%2.48B	-6.34%2.54B	10.21%2.41B	10.82%2.41B	--2.45B	5.64%2.71B	0.93%2.19B	--2.17B	6.72%2.56B	--2.17B
Current liabilities
Long term loan	-52.79%483M	-74.98%357.33M	-69.00%692.33M	-69.00%692.33M	--1.02B	-31.74%1.43B	-17.51%2.23B	--2.23B	-26.49%2.09B	--2.71B
Estimate liabilities	-43.84%1.41M	--77.9K	--5.33M	--3.41M	--2.51M	--0	----	----	----	----
Deferred tax liabilities	-97.09%20.7K	268.49%307.28K	--882.58K	--595.63K	--712.39K	--83.39K	----	----	--0	----
Long term deferred income	148.16%82.34M	144.56%83.74M	246.14%82.66M	123.37%55.11M	--33.18M	30.59%34.24M	39.59%23.88M	--24.67M	231.07%26.22M	--17.11M
Lease liabilities	-10.67%193.7M	1,743.84%188.12M	1,681.27%186.09M	1,779.90%199.86M	--216.83M	226.35%10.2M	208.53%10.45M	--10.63M	-24.69%3.13M	--3.39M
Other non current liabilities	----	----	----	----	----	--0	----	----	----	----
Total non current liabilities	-40.41%760.47M	-57.25%629.58M	-57.34%967.3M	-58.06%951.32M	--1.28B	-30.59%1.47B	-16.87%2.27B	--2.27B	-25.78%2.12B	--2.73B
Total liabilities	-13.08%3.24B	-24.27%3.17B	-24.16%3.38B	-24.35%3.36B	--3.73B	-10.77%4.18B	-8.99%4.46B	--4.44B	-10.94%4.68B	--4.9B
Shareholders equity
Paid-in capital	0.00%2.22B	0.00%2.22B	11.14%2.22B	11.14%2.22B	--2.22B	11.14%2.22B	0.00%2B	--2B	0.00%2B	--2B
Capital reserve funds	0.91%3.26B	0.69%3.25B	33.45%3.24B	33.09%3.23B	--3.23B	32.87%3.23B	0.00%2.43B	--2.43B	0.00%2.43B	--2.43B
Surplus reserve funds	132.85%172.32M	132.85%172.32M	117.80%74M	117.80%74M	--74M	117.80%74M	48.07%33.98M	--33.98M	48.07%33.98M	--22.95M
Retained profit	95.20%1.67B	93.71%1.31B	73.96%1.11B	58.56%862.36M	--853.66M	121.12%678.21M	68.92%639.01M	--543.87M	48.60%306.72M	--378.3M
Less:Treasury stock	--0	--0	----	----	----	----	----	----	----	----
Other composite income	--0	--0	----	----	----	----	----	----	----	----
Ordinary risk reserve funds	--0	--0	----	----	----	----	----	----	----	----
Specific reserves	--0	--0	----	----	----	----	----	----	----	----
Shareholders equity without minority interests	14.74%7.32B	12.18%6.96B	30.34%6.65B	27.67%6.39B	--6.38B	30.04%6.2B	5.62%5.1B	--5.01B	2.39%4.77B	--4.83B
Minority interests	114.65%12.88M	114.47%12.87M	81.12%10.87M	-0.00%6M	--6M	-0.01%6M	-0.02%6M	--6M	0.01%6M	--6M
Total shareholder equity	14.83%7.33B	12.28%6.97B	30.40%6.66B	27.63%6.4B	--6.39B	30.00%6.21B	5.62%5.11B	--5.01B	2.39%4.78B	--4.84B
Total liabilityies and equity	4.55%10.57B	-2.42%10.14B	4.99%10.04B	3.21%9.76B	--10.11B	9.82%10.39B	-1.73%9.57B	--9.46B	-4.67%9.46B	--9.73B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	Unqualified opinion	--
Auditor	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

301301 Yili Chuanning Biotechnology

Yili Chuanning Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target